Karen Baker Mesa, PA

Karen Baker Mesa practices at South Florida Dermatology Group, Inc. in Coral Gables, Florida.

Karen Baker Mesa's NPI, 1023165875, was assigned on January 4, 2007. Karen Baker Mesa holds Florida license PA 3609.

Karen Baker Mesa's primary practice is South Florida Dermatology Group, Inc., at 401 Coral Way, Coral Gables, FL 33134 in Miami-Dade County. The practice phone is (305) 445-2941.

Karen Baker Mesa's primary practice is South Florida Dermatology Group, Inc. in Coral Gables, Florida. The medical group on file is South Florida Dermatology. Dmand AI also links Karen Baker Mesa to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karen Baker Mesa practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Karen Baker Mesa's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Karen Baker Mesa is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Karen Baker Mesa is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, scalp rash and skin cyst among the conditions Karen Baker Mesa treats.

CMS data shows 327 Medicare services from Karen Baker Mesa across 7 procedure codes in 2024, for 106 Medicare patients. Medicare paid $23,776 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Karen Baker Mesa in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Karen Baker Mesa's median patient age at 40, with 64% women.

In 2024, Karen Baker Mesa wrote 1,448 Medicare Part D claims for 378 patients. 97% of them were for generic drugs. CMS names the drug for 1,335 of them, across 22 drugs with 11 or more claims each, at $29,193 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Karen Baker Mesa for performance year 2024, reported as part of a group. Karen Baker Mesa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 52 general payments to Karen Baker Mesa from 16 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 88% of the total. Bristol-Myers Squibb Company paid the most, $317.